Low Molecular Weight Heparin Market Opportunities And Key Insights 2022

1
Low Molecular Weight Heparin Market Global
Analysis and Forecast to 2028

• Published Date Dec 2021

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Low Molecular Weight Heparin Market Forecast to
  2028 - COVID-19 Impact and Global Analysis By
  Product Type (Enoxaparin, Dalteparin, Tinzaparin,
  Fraxiparine, Nadroparin, and Others), Packaging
  (Multi-Vials and Prefilled Syringes), Application
  Deep Vein Thrombosis, Acute Coronary Syndrome
  (ACS), Pulmonary Embolism, and Others, and End
  User (Hospitals, Clinics, Ambulatory Surgical
  Centers, and Others), and Geography

3
Low Molecular Weight Heparin Market Overview
Email sales_at_theinsightpartners.com

• The low molecular weight heparin market is
  expected to grow from US 3,658.27 million in
  2021 to US 5,733.96 million by 2028 it is
  estimated to grow at a CAGR of 6.6 from 2021 to
  2028.
• Low molecular weight heparin (LMWH) is a class of
  anticoagulants. They are used to prevent blood
  clots and to treat venous thromboembolism (deep
  vein thrombosis and pulmonary embolism) and treat
  myocardial infarction. LMWHs are defined as
  heparin salts with an average molecular weight of
  less than 8,000 Da and in which at least 60 of
  all chains have a molecular weight of less than
  8,000 Da. These are obtained by various methods
  of fractionation or depolymerization of polymeric
  heparin. Low molecular weight heparin offers
  advantages over heparin in that it has better
  bioavailability and longer half-life, simplified
  dosing, predictable anticoagulant response, lower
  risk of HIT, and lower risk of osteoporosis.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Product Type (Enoxaparin, Dalteparin,
  Tinzaparin, Fraxiparine, Nadroparin, and Others)
• Application (Deep Vein Thrombosis, Acute Coronary
  Syndrome (ACS), Pulmonary Embolism, and Others)
• End-User (Hospitals, Clinics, Ambulatory Surgical
  Centers, and Others)

Download Sample Here
5
Low Molecular Weight Heparin Market Value
Email sales_at_theinsightpartners.com

• CAGR of 6.6
• (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Aspen Holdings
• Changzhou Qianhong Bio-Pharma
• Leopharma A/S
• Teva Pharmaceutical Industries Ltd.
• B. Braun Medical, Inc.
• Pfizer, Inc.
• Sanofi
• Dr. Reddy's Laboratories Limited
• Abbott
• Novartis AG

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com